Nureflex Kinder

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Nureflex Kinder

Quick Facts

Property Description
Active Ingredient Ibuprofen
Form Oral Suspension (Liquid)
Pharmacological Class Non-steroidal Anti-inflammatory Drug (NSAID)
General Purpose Relief from Fever, Pain, and Inflammation
Origin Synthetic (Propionic acid derivative)

Nureflex Kinder: Defining the Medicine

Nureflex Kinder is a therapeutic preparation classified as a Non-steroidal Anti-inflammatory Drug (NSAID), an agent clinically recognized for managing pain and fever. This medicine is specifically formulated as an Over-The-Counter (OTC) solution for the pediatric population.

The product is centered entirely on the single active pharmaceutical ingredient, Ibuprofen (INN). As an NSAID, Ibuprofen provides a potent analgesic and antipyretic effect, with the crucial added benefit of mitigating inflammation. This comprehensive function serves to reduce fever and discomfort through its established pharmacological properties.

Composition, Form, and Origin

The preparation's active substance is Ibuprofen, a compound with a synthetic origin that belongs to the chemical class of propionic acid derivatives. Nureflex Kinder is delivered in the form of an oral suspension, a liquid where the Ibuprofen particles are dispersed within an aqueous vehicle.

This liquid form is purposefully chosen for ease of administration to children, eliminating the need for swallowing solid dosage forms and often incorporating specific flavorings to aid patient compliance. The single-ingredient composition ensures a straightforward pharmacological profile, fully supported by its core structure.

Understanding the General Purpose (NSAID Action)

The core purpose of Nureflex Kinder is to provide prompt symptomatic relief during common childhood acute conditions, such as reducing a high temperature or easing generalized physical discomfort. This is achieved through Ibuprofen's targeted action: the inhibition of the cyclooxygenase (COX) enzyme system.

This high-level mechanism prevents the excessive production of prostaglandins, which are key chemical messengers that trigger fever, pain signaling, and inflammatory swelling. By controlling the synthesis of these compounds, the medicine delivers a foundational action that effectively manages the three primary symptoms simultaneously in the targeted patient group.

Regulatory References

  1. MedlinePlus: Over-the-counter pain relievers

What side effects are possible with Nureflex Kinder?

Possible Side Effects and Safety Information

Nureflex Kinder (ibuprofen) is generally well-tolerated when used at the lowest effective dose for the shortest necessary duration. However, like all medicines, it can cause side effects. Understanding potential risks is crucial for safe use.

Common Side Effects

The most frequently reported adverse effects involve the gastrointestinal system:

  • Abdominal pain or discomfort
  • Nausea and vomiting
  • Heartburn, indigestion
  • Diarrhea or flatulence

Giving the medicine with food or milk can help minimize stomach irritation.

Serious Side Effects (Seek Medical Attention Immediately)

Although rare, some side effects require immediate medical attention. Stop treatment and contact a doctor or emergency services if your child experiences any of the following:

  • Signs of Allergic Reaction: Swelling of the face, tongue, or throat; difficulty breathing or wheezing; severe, blistering, or peeling skin rash (e.g., Stevens-Johnson syndrome, DRESS).
  • Signs of Gastrointestinal Bleeding: Passing black, tarry, or bloody stools; vomiting blood or material that looks like coffee grounds; severe, persistent stomach pain.
  • Signs of Kidney Problems: A significant decrease in the amount of urine, blood in the urine, or unexplained swelling (edema).
  • Signs of Heart or Circulation Issues: Sudden weakness on one side of the body, slurred speech, chest pain, or rapid heartbeat (risk is higher with high doses and prolonged use).

Contraindications and Warnings

Do not administer Nureflex Kinder if your child has an allergy to ibuprofen, aspirin, or other Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), or if they have a history of stomach ulcers, active bleeding, severe heart failure, or severe kidney/liver impairment. Use with caution if your child has asthma, Systemic Lupus Erythematosus (SLE), or is severely dehydrated (due to risk of kidney problems).

Overdose and Emergency Response

Overdose and When to Seek Help

This section details the officially documented overdose profile for Ibuprofen, based strictly on government regulatory labeling and prescribing information.

Scope Point Official Regulatory Statement
Documented Presentations Overdose frequently manifests with initial gastrointestinal effects, including nausea, vomiting, and epigastric pain. Concurrent central nervous system effects such as drowsiness, dizziness, tinnitus, and headache are also documented.
Severe Outcomes Severe and potentially life-threatening outcomes documented include acute renal failure, significant metabolic acidosis, hypotension, and severe CNS manifestations like convulsions and coma. In children, apnoea (cessation of breathing) is a noted risk.
Emergency Action Seek immediate medical attention for any suspected overdose. Contact emergency services immediately if severe signs such as loss of consciousness, profound difficulty breathing, or seizures are observed.
Antidote Status No specific pharmacological antidote is known or available for Ibuprofen overdose; management is exclusively supportive and symptomatic.
Special Considerations Pediatric patients are specifically noted to be susceptible to severe CNS effects. Patients with pre-existing hepatic or renal impairment face an increased risk of severe organ damage following overexposure.

Regulatory Management Basis

The official guidance mandates close medical monitoring of the patient for a required observation period. Treatment focuses on stabilizing the patient and mitigating further absorption through procedures like oral activated charcoal administration, particularly if performed early. The requirement for urgent medical help is triggered by any suspected ingestion exceeding therapeutic levels, given the documented risk of rapid progression to serious metabolic or organ damage.

Therapeutic Uses of Nureflex Kinder

What Nureflex Kinder Treats: Main Uses and Benefits

The primary purpose of Nureflex Kinder is to offer symptomatic relief by managing distressing symptoms and supporting the patient during acute episodes. Its core therapeutic function is applied across domains where short-term symptom management is appropriate. This medicine is commonly used to help with symptoms related to systemic imbalance and temporary discomfort.

Nureflex Kinder helps address symptom clusters that may become intense or disruptive in conditions characterized by periods of heightened symptoms. It is relevant for easing discomfort from fever, headaches, earaches, toothaches, post-vaccination soreness, and aches associated with colds or flu. This supportive relief contributes to improved comfort during periods of heightened symptoms.

Quick Fact: Relief for Fever and Pain

Nureflex Kinder plays a role in managing symptoms related to both systemic heat (fever) and localized discomfort (pain), and may assist with easing the overall symptom load.

Eligibility and Restrictions for Use

Who can and cannot use Nureflex Kinder?

Category Official Eligibility Status
Populations Allowed Permitted for the pediatric population from 3 months of age and weighing at least 5 kg. Use is also permitted in adults unable to swallow solid dosage forms.
Absolute Contraindications Prohibited for patients with known NSAID hypersensitivity (including aspirin-induced asthma, rhinitis, or urticaria). Also prohibited in severe heart, renal, or hepatic failure (NYHA Class IV), active/recurrent peptic ulcer/haemorrhage, or a history of GI bleeding related to prior NSAID use.
Age Limitations Not recommended for infants under 3 months or under 5 kg. The elderly are permitted users but require special caution due to the increased risk of gastrointestinal bleeding.
Pregnancy/Lactation Contraindicated during the third trimester of pregnancy. Permitted for short-term use in breastfeeding women, though consultation is advised.
Conditional Restrictions Caution is mandatory for dehydrated children/adolescents due to the risk of renal impairment. Restriction applies to patients with non-severe organ impairment, Systemic Lupus Erythematosus (SLE), or who are immediately before or after CABG surgery.

This eligibility profile strictly defines the authorized user base according to regulatory documents. Use is restricted by minimum age and weight thresholds, and absolutely prohibited for specific populations with pre-existing conditions that increase the risk of gastrointestinal bleeding or organ deterioration.

What should I know about interactions with other medicines?

Interactions with Other Medicines and Products

The official regulatory profile for Nureflex Kinder (Ibuprofen) identifies specific interaction patterns primarily concerning bleeding risk, renal function, and drug exposure. Combining the active ingredient with other Non-steroidal Anti-inflammatory Drugs (NSAIDs), including COX-2 inhibitors, is generally restricted due to the heightened risk of adverse effects. Co-administration with anti-inflammatory doses of Acetylsalicylic Acid (Aspirin) is also officially not recommended.

Documented Interaction Patterns

Interacting Substance Class Official Interaction Outcome Timing Restriction
Anticoagulants/Corticosteroids Increased risk of gastrointestinal bleeding/ulceration. None documented
Diuretics/ACE Inhibitors Reduction of antihypertensive and natriuretic effects. None documented
Lithium/Methotrexate Clearance is reduced, leading to increased plasma levels of these drugs. None documented
Low-Dose Aspirin (antiplatelet) Potential interference with antiplatelet effect. Must be taken 8 hours before or 30 minutes after aspirin.

These interactions are classified based on official regulatory data. The concurrent use of CYP2C9 inhibitors may increase Ibuprofen exposure due to reduced metabolism. Furthermore, official cautions note that administration to dehydrated children may increase the risk of renal impairment. Taking the medicine with food delays the rate of absorption and reduces peak plasma concentrations.

Mechanism of Action

The mechanism of action for Ibuprofen in Nureflex Kinder is defined by its ability to engage and modulate the PGE2 signaling pathway, which is central to the initiation of inflammatory, nociceptive, and pyrogenic signaling. The molecule functions as a non-selective, competitive inhibitor of the Cyclooxygenase (COX) enzyme isoforms, COX-1 and COX-2. This targeted enzyme modulation interrupts the metabolic conversion of arachidonic acid into mediator molecules, including those involved in inflammatory and thermal regulation.


Central Regulation of Body Temperature

The drug's mechanism of action includes modulating the central thermoregulatory set point within the hypothalamus. By reducing PGE2 synthesis in this central region, the mechanism effectively neutralizes the chemical signal that prompts the body to unnaturally raise its temperature. This leads to the physiological consequence of activating heat dissipation processes, such as vasodilation (widening of blood vessels), which facilitates the physiological consequence of heat dissipation.


Modulating Peripheral Pain Sensitization

The mechanism concurrently operates at the periphery by reducing the chemical components of local inflammatory signaling. The reduction in PGE2 limits its ability to chemically sensitize peripheral nociceptors (pain-sensing neurons). This decreases the hyper-responsiveness of the sensory nerves at sites of irritation, effectively raising the threshold required to trigger a pain signal. This action reduces the functional impact of PGE2 on sensory nerve thresholds, which results in the physiological consequence of lowered nociceptor excitability.

Dosage and Administration Information

How to Use Nureflex Kinder: Administration Guidelines

This section details the administration principles for Nureflex Kinder (Ibuprofen 100 mg/5 mL oral suspension) for pediatric use. It does not contain information on efficacy, safety, or therapeutic indications.


Administration Scope

Feature Requirement
Route of Administration The suspension is intended solely for oral administration.
Dosing Schedule Dosing is weight-based, utilizing a single dose of 7 to 10 mg of Ibuprofen per kilogram of the child’s body weight. The maximum total intake must not exceed 30 mg/kg in a 24-hour period.
Timing in Relation to Meals Administration may occur without regard to meals, but it is advised to take the dose with food or milk if the child experiences stomach discomfort.
Preparation Requirements The bottle containing the oral suspension must be shaken well immediately before any dose is measured and administered.
Age-Group Rules The product is generally intended for children aged 3 months and over who weigh at least 5 kg. Use in children 3–5 months should not exceed a 24-hour period without professional advice.

Procedural Structure and Constraints

The medicine is used in an as-needed frequency pattern for short-term symptomatic relief. A precise administration protocol is followed to ensure adherence to established limits:

  1. Determine the dose using the child's weight or appropriate age tier, referencing the dosing chart.
  2. Use the enclosed dosing device (e.g., measuring syringe) to accurately draw the calculated volume of suspension.
  3. Maintain a minimum interval of 4 to 6 hours between doses; the total frequency is capped at a maximum of 3 to 4 times in 24 hours.
  4. Usage is restricted to short-term relief only, generally no more than three days for fever or pain in children over six months.

This protocol ensures that the administration of the oral suspension is accurately measured, correctly timed, and contained within the maximum dosage and short-term duration parameters.

Recent Clinical Evidence

Research evidence / Overview of Studies for Nureflex Kinder


Evidence for Use in Symptomatic Management of Acute Fever

The research surrounding the use of Ibuprofen, the active ingredient in Nureflex Kinder, related to conditions characterized by fever in children is largely based on short-term, randomized controlled trials (RCTs). These are considered a high-quality type of study as they are designed to minimize bias in the outcomes observed. Studies primarily measured outcomes related to systemic or functional imbalance, specifically focusing on the change in the child's body temperature over a short period, such as the first four to six hours post-administration.

Studies reported measurements of temperature changes that were observed in the group receiving the active ingredient compared to the group receiving a placebo. Research highlights changes measured during the study period for fever associated with common conditions. However, the existing studies provide limited insight into outcomes that extend beyond the initial acute phase. Long-term effects are not fully established for repeated use over many days.

Evidence for Use in Symptomatic Management of Mild to Moderate Pain

Related to conditions involving periods of heightened symptoms (pain) in children—including discomfort from headaches, earaches, and toothaches—the active ingredient was evaluated in a similar body of research, primarily RCTs and meta-analyses. Research examined outcomes related to physical discomfort using validated tools, where patient-reported outcomes describing perceived discomfort were key.

Studies examined how pain intensity scores evolved in the group receiving the active ingredient compared to the group receiving a placebo. Findings from multiple trials help contextualize how patients reported their experience during episodes where symptoms become more noticeable. A key limitation is that most research exploring short-term changes in pain focused on single-dose or very brief treatment periods, meaning follow-up durations were limited. Data for certain groups remain insufficient, such as those with chronic pain conditions or very young infants.

The Comparative Research Landscape

The research landscape includes studies where the active ingredient was observed in trials alongside an inactive placebo, as well as head-to-head comparisons with other common antipyretic and analgesic medicines. When findings from different agents are compared, research highlights patterns of change measured during the study period that may show certain short-term differences in the speed of the observed outcome for both pain and fever. The studies describe that differences in outcomes related to physiological strain or stress were often observed to be modest when assessed over the short term.

Key Studies & References Fever in under 5s: assessment and initial management (NICE Guideline NG143)

Frequently Asked Questions (FAQ)

Common questions about Nureflex Kinder (FAQ)


Q: How quickly do people typically expect Nureflex Kinder to start working?

Official drug information and pharmacokinetic data, which describe how the medicine is processed by the body, indicate when the active ingredient is at its highest concentration. For Ibuprofen oral suspension, peak concentrations in the blood are typically reached within approximately 1 to 2 hours after the dose is given. This timeframe generally corresponds to the period when the medicine's concentration is highest.


Q: How long does the effect of Nureflex Kinder usually last?

Regulatory guidance on administration frequency gives an indication of the expected duration of the drug’s effects. Official documents instruct that a minimum of 4 to 6 hours must pass between doses. This interval is established to maintain symptomatic relief while adhering to safety limits.


Q: Are there any specific foods or drinks that should be avoided when taking Nureflex Kinder?

Official information explicitly cautions against combining Ibuprofen with alcohol because using them together may increase the risk of certain gastrointestinal side effects. No other specific foods or common non-alcoholic drinks are typically cautioned against in regulatory product information.


Q: What are the known themes in research about the long-term use of Nureflex Kinder?

Research themes noted in official documents state that long-term effects are not fully established and that follow-up durations are limited. Therefore, official guidance recommends that use should be limited to short-term relief only to minimize potential risks, particularly with repeated use.


Q: Do people ask about the ingredients used to color or flavor Nureflex Kinder liquid?

Yes, official product information, such as the list of excipients, details all the components of the oral suspension. This includes any flavorings (e.g., berry or strawberry) and colorings that are added to help improve the medicine's acceptance for children.


Q: What is the maximum single dose officially described for children?

Official dosing guidelines establish the limits for administering the medicine. The maximum single amount is weight-based, not to exceed 10 milligrams per kilogram of the child's body weight. The total amount given over a 24-hour period is also limited by regulatory guidelines.


Q: Is Nureflex Kinder the same as Ibuprofen for children?

Nureflex Kinder is a specific brand name product. Official documents confirm that the medicine's single active ingredient is Ibuprofen. Therefore, the medicine contains the same primary active drug substance as other children's products containing Ibuprofen.


Q: Is there a taste to the liquid version of Nureflex Kinder?

Official product information confirms that the oral suspension includes flavoring agents. These flavorings are added to the liquid to help improve patient acceptance and ease of administration to children.


Q: Can Nureflex Kinder be given to children under the age limit listed on the package?

Regulatory guidance strictly defines the appropriate user population. Official documents state that the product is not recommended for infants under 3 months of age or those weighing under 5 kilograms of body weight.


Q: Is feeling sleepy a possible effect of Nureflex Kinder?

Official regulatory documents list known side effects that have been reported by users. Somnolence, which is a term for drowsiness or sleepiness, is described as an uncommon undesirable effect associated with the active ingredient.


Q: Can I give Nureflex Kinder if my child is taking an antibiotic?

Official interaction lists do not typically include a general caution against combining Ibuprofen with common antibiotics. However, all instances of co-administration are advised to be discussed with a healthcare professional.


Q: Is there a maximum number of days Nureflex Kinder is generally used for?

Regulatory documents restrict the use of the medicine for children's fever or pain relief to a short-term duration. Use is typically limited to no more than three days for children over six months without first seeking further medical advice.


Q: Can Nureflex Kinder be used for pain after a vaccination?

Official documents describe the medicine's general therapeutic indications. The drug is indicated for the temporary relief of aches and pains, which includes those that may be associated with common procedures such as immunization.


Q: Is it okay to use Nureflex Kinder if my child has a common cold?

Official indications for use include the temporary relief of minor aches and pains, which covers symptoms associated with the common cold.


Q: Why do official documents emphasize checking the ingredient list for other medicines?

Official regulatory warnings emphasize checking ingredients because using Ibuprofen alongside other medicines that contain Non-steroidal Anti-inflammatory Drugs (NSAIDs) can lead to exceeding the maximum total amount recommended. This significantly increases the risk of serious side effects like stomach bleeding.


Q: Do users often search for information about a rash after taking Nureflex Kinder?

Official regulatory documents list rash, urticaria (hives), and pruritus (itching) among the reported side effects. These skin reactions are listed as common or uncommon adverse effects associated with the active ingredient.


Q: Can I give Nureflex Kinder at the same time as cold medicine?

Official warnings caution against combining Nureflex Kinder with other pain relievers or fever reducers. Many cold and flu medicines contain NSAIDs, which can lead to exceeding the maximum recommended daily amount or an increased risk of side effects.


Q: Is there a possibility of allergic reactions to Nureflex Kinder?

Yes, official warnings state that Ibuprofen may cause a severe allergic reaction, particularly in people with an aspirin allergy. The regulatory information lists specific symptoms such as hives, facial swelling, or wheezing that require immediate medical attention.


Q: Does taking Nureflex Kinder require any special precautions regarding sun exposure?

Regulatory documents list potential side effects that include reactions to light. Photosensitivity reaction, which is an increased sensitivity of the skin to sunlight, is described as an uncommon adverse effect associated with the active ingredient.


Q: What do the official sources say about using Nureflex Kinder for earache?

The official indications for use include the temporary relief of minor aches and pains. This covers discomfort from general aches, headaches, toothaches, and earache.


Q: Are there warnings about giving Nureflex Kinder to dehydrated children?

Official precautions explicitly warn that there is an increased risk of renal impairment (kidney problems) in dehydrated children and adolescents. Official documents recommend consulting a doctor if the child has experienced significant fluid loss.


Q: Does Nureflex Kinder affect sleep?

Regulatory documents address potential effects on the central nervous system. These side effects can include both insomnia (difficulty sleeping) and somnolence (drowsiness) and are listed as uncommon adverse effects.

How should Nureflex Kinder be stored and disposed of?

The storage and disposal of Nureflex Kinder (Ibuprofen 100 mg/5 mL Oral Suspension) must adhere strictly to the requirements defined in regulatory labeling to maintain the product's stability and prevent accidental exposure.

Storage Conditions

Aspect Requirement
Temperature: Store at Controlled Room Temperature, typically 20 C to 25 C (68 F to 77 F), or below 25 C [SmPC/FDA].
Protection: Do not freeze the suspension, protect from light, and store in a dry place.
Container/Stability: Keep in the original container with the cap replaced tightly after each use. Discard the remainder 6 months after first opening the bottle.
Child Safety: Store the product out of the sight and reach of children [SmPC/DailyMed].

Disposal

Disposal must comply with all local waste disposal regulations. If a drug take-back program is unavailable, unused or expired product should be removed from its container, mixed with an unappealing substance (e.g., used coffee grounds), placed in a sealed bag, and thrown into the household trash [FDA]. Do not flush the medicine unless specifically instructed by the label.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Nureflex Kinder found in:

A-Z Index: